5-Day Rally Sends GE HealthCare Technologies Stock Up 11%
GE HealthCare Technologies (GEHC) stock hit day 5 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 11% return. The company has gained about $3.5 Bil in value over the last 5 days, with its current market capitalization at about $36 Bil. The stock remains 0.3% above its value at the end of 2024. This compares with year-to-date returns of 14% for the S&P 500.
GE HealthCare’s recent streak saw momentum from its $2.3B Intelerad acquisition, fortifying cloud-AI imaging, alongside an FDA 510(k) submission for its innovative Photonova Spectra AI-powered CT. Bolstered by Q3 earnings that surpassed expectations, lifting 2025 EPS guidance, and reaffirmed “Buy” ratings, the company demonstrated robust growth despite tariff headwinds.
What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades.For quick background, GEHC is a global innovator in medical technology, pharmaceutical diagnostics, and digital solutions, serving over 160 countries with extensive sales, service teams, and manufacturing sites worldwide.
Comparing GEHC Stock Returns With The S&P 500
The following table summarizes the return for GEHC stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | GEHC | S&P 500 |
|---|---|---|
| 1D | 2.3% | 1.5% |
| 5D (Current Streak) | 10.8% | 0.5% |
| 1M (21D) | 0.1% | -1.3% |
| 3M (63D) | 5.6% | 3.7% |
| YTD 2025 | 0.3% | 14.0% |
| 2024 | 1.3% | 23.3% |
| 2023 | 24.2% | |
| 2022 | -19.4% |
However, big gains can follow sharp reversals – but how has GEHC behaved after prior drops? See GEHC Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 48 S&P constituents with 3 days or more of consecutive gains and 9 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 34 | 4 |
| 4D | 6 | 3 |
| 5D | 5 | 0 |
| 6D | 1 | 2 |
| 7D or more | 2 | 0 |
| Total >=3 D | 48 | 9 |
Key Financials for GE HealthCare Technologies (GEHC)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $19.6 Bil | $19.7 Bil |
| Operating Income | $2.4 Bil | $2.6 Bil |
| Net Income | $1.6 Bil | $2.0 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ2 | 2025 FQ3 |
|---|---|---|
| Revenues | $5.0 Bil | $5.1 Bil |
| Operating Income | $654.0 Mil | $653.0 Mil |
| Net Income | $486.0 Mil | $446.0 Mil |
While GEHC stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.